Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

20 Mar 2023 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..